Kantonsspital St.Gallen
login

Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS)

Markus Weber, Christoph Neuwirth & Nathalie Braun

abstract

The primary objective is to evaluate the long-term safety and tolerability of BIIB078 in participants with chromosome 9 open reading frame 72-amyotrophic lateral sclerosis (C9ORF72-ALS).

The secondary objective is to evaluate the pharmacokinectic (PK) of BIIB078 in participants with C9ORF72-ALS.
   
type of project clinical studies
status ongoing - follow up
start of project 2020
end of project 2023
study design open lable extension
responsible person Weber, Markus